Joaquim Calado, René Santer, José Rueff  Kidney International 

Slides:



Advertisements
Similar presentations
Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
Advertisements

Volume 79, Pages S3-S8 (April 2011)
A.M. Thompson, T.G. Pickering  Kidney International 
Nat. Rev. Nephrol. doi: /nrneph
Buffer transport in peritoneal dialysis
Frederik Persson, Peter Rossing  Kidney International Supplements 
Renal manifestations in Fabry disease and therapeutic options
Anemia management in chronic kidney disease
Glucose handling by the kidney
Volume 83, Issue 3, Pages (March 2013)
Part 9.
Figure 2 Glucose handling by the kidney
Volume 86, Issue 4, Pages (October 2014)
Kidney International Supplements 
Blaithin A. McMahon, Patrick Thomas Murray  Kidney International 
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Prehypertension and chronic kidney disease: the ox or the plow?
Progression of renal failure and hypertensive nephrosclerosis
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 79, Pages S3-S8 (April 2011)
‘Progressive diabetic nephropathy. How useful is microalbuminuria
Francesco Paolo Schena  Kidney International 
Chapter 3: Management of progression and complications of CKD
Chapter 5: Referral to specialists and models of care
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
Better nephrology for mice—and man
Volume 77, Issue 8, Pages (April 2010)
James F. List, Jean M. Whaley  Kidney International 
End-stage renal disease in living kidney donors
Volume 77, Issue 1, Pages 5-6 (January 2010)
Infection and chronic allograft dysfunction
Comorbidity and confounding in end-stage renal disease
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Volume 89, Issue 5, Pages (May 2016)
The epidemiology of chronic kidney disease
Predicting an allograft's fate
U-shaped effect of eGFR and mortality
Volume 71, Issue 6, Pages (March 2007)
Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target?  Hatem Amer, Matthew D. Griffin  Kidney International 
It takes two to Twist Kidney International
Extracorporeal therapy in sepsis: are we there yet?
Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate  N. Takahashi, G. Boysen, F.
Volume 84, Issue 5, Pages (November 2013)
Methods for guideline development
Volume 93, Issue 1, Pages (January 2018)
Nephrology Crossword: Glomerulonephritis
Volume 85, Issue 5, Pages (May 2014)
Volume 80, Issue 3, Pages (August 2011)
Prehypertension: is it relevant for nephrologists?
Volume 87, Issue 5, Pages (May 2015)
Homocysteine, renal function, and risk of cardiovascular disease
Douglas G Matsell, Colin T White  Kidney International 
Volume 73, Issue 9, Pages (May 2008)
Volume 74, Issue 9, Pages (November 2008)
Volume 80, Issue 10, Pages (November 2011)
Vikas R. Dharnidharka, Michael E. Seifert  Kidney International 
Volume 56, Pages S37-S40 (November 1999)
Glucose handling by the kidney
Glucose reabsorption in the kidney.
The international realities of live donor kidney transplantation
Renal vascular disease in the elderly
Kidney and hypertension
Daniel L. Roden, Shane T. Grey  Kidney International 
The Ebf1 knockout mouse and glomerular maturation
Ronen Levi, Justin Silver  Kidney International 
Update on Cystatin C: Incorporation Into Clinical Practice
Presentation transcript:

Effect of kidney disease on glucose handling (including genetic defects)  Joaquim Calado, René Santer, José Rueff  Kidney International  Volume 79, Pages S7-S13 (March 2011) DOI: 10.1038/ki.2010.510 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Correlation between tubular glucose load and tubular glucose reabsorption (TG) in various types of renal glucosuria. GFR, glomerular filtration rate; PG, plasma glucose concentration; TmG, maximum of tubular glucose reabsorption. The hatched area is the splay, the difference between actual and ideal reabsorption that is exhibited when the reabsorption curve shows a nonlinear transition as the TmG is reached.6 Copyright 1987, Int Pediatr Nephrol Assoc. Kidney International 2011 79, S7-S13DOI: (10.1038/ki.2010.510) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Comparison of the genomic structure of sodium–glucose cotransporter (SGLT)1 and SGLT2. There is a high degree of similarity both in the sequence and in the intron–exon organization. Exon sizes are to scale.14 Copyright 2003, Am Soc Nephrol. Kidney International 2011 79, S7-S13DOI: (10.1038/ki.2010.510) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Results of mutation analyses of the human Na+–glucose cotransporter gene SLC5A2 (SGLT2). Coded transmembrane domains 1–14 are shown as dark gray boxes.16 The figure has been updated with five novel mutations presented by Yu et al.,57 at the World Congress of Nephrology, Milan, 22–26 May 2009. Adapted with permission from Calado et al.16 Copyright 2008, published by Oxford University Press on behalf of ERA-EDTA. Kidney International 2011 79, S7-S13DOI: (10.1038/ki.2010.510) Copyright © 2011 International Society of Nephrology Terms and Conditions